Led by Editors-in-Chief Irit Ben-Aharon and Florian Lordick, ESMO Gastrointestinal Oncology is a new, peer-reviewed, open access journal from ESMO.
It is the European Society for Medical Oncology's latest peer-reviewed open access journal, dedicated to publishing high-quality research and commenting on all aspects of the diagnosis, treatment and understanding of gastrointestinal cancers.
The journal aims to publish experimental, translational, diagnostic and therapeutic research. Specific areas of interest include but are not limited to gastrointestinal cancer biology and epidemiology, prevention and early detection, advances in molecular, genetic and imaging diagnostics, therapeutic studies from pre-clinical to clinical (phase I-IV) with a focus on targeted and immunotherapy, translational research, patient-oriented studies, psychosocial aspects of disease, treatment of long-term morbidity and survivorship, palliative and supportive care, novel methods and clinical protocols. The journal welcomes original articles, reviews, mini reviews, editorials, research methods and clinical trial summaries, and correspondence. In addition, it provides in-depth commentaries from leading experts and engages in active debate on important topics via its pro and con discussion section.
Proceedings from the ESMO Gastrointestinal Cancers Congress will be disseminated via ESMO Gastrointestinal Oncology.
ESMO Gastrointestinal Oncology is committed to providing swift review and publication supported by our team of experienced international experts and key opinion leaders. The journal will provide essential reading for cancer researchers, clinician-scientists, clinicians with a focus gastrointestinal cancer, patient advocates and all health care professionals with a specific interest in gastrointestinal cancers. The journal rapidly disseminates the best innovative clinical and translational research and aims to improve the quality of education, prevention, diagnosis, treatment and patient care worldwide.
ESMO members who are corresponding authors are eligible for a discount of 60% off the open-access publication fee.